Literature DB >> 17060662

Granulocyte colony-stimulating factor.

Kürsat Kaptan, Cengiz Beyan, Ahmet Ifran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17060662      PMCID： PMC1609138          DOI： 10.1503/cmaj.1060064

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases.

Authors:  P Anderlini; J D Rizzo; M L Nugent; N Schmitz; R E Champlin; M M Horowitz
Journal:  Bone Marrow Transplant       Date:  2001-04       Impact factor: 5.483

2.  A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.

Authors:  R LeBlanc; J Roy; C Demers; L Vu; G Cantin
Journal:  Bone Marrow Transplant       Date:  1999-05       Impact factor: 5.483

3.  Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. A possible new recombinant granulocyte colony-stimulating factor toxicity.

Authors:  J A Conti; H I Scher
Journal:  Cancer       Date:  1992-12-01       Impact factor: 6.860

4.  Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.

Authors:  Woei-Cherng Shyu; Shinn-Zong Lin; Chau-Chin Lee; Demeral David Liu; Hung Li
Journal:  CMAJ       Date:  2006-03-03       Impact factor: 8.262

5.  Allogeneic blood stem cell transplantation: considerations for donors.

Authors:  P Anderlini; M Körbling; D Dale; A Gratwohl; N Schmitz; D Stroncek; C Howe; S Leitman; M Horowitz; E Gluckman; S Rowley; D Przepiorka; R Champlin
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

6.  Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF)

Authors:  A Lindemann; B Rumberger
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

7.  Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors.

Authors:  P Topcuoglu; M Arat; K Dalva; M Ozcan
Journal:  Bone Marrow Transplant       Date:  2004-01       Impact factor: 5.483
  7 in total
  1 in total

1.  Effects of recombinant human granulocyte colony-stimulating factor (filgrastim) on ECG parameters in neutropenic patients: a single-centre, prospective study.

Authors:  Ozlem Guneysel; Ozge Ecmel Onur; Arzu Denizbasi
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.